Clot Management Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Clot Management Devices Market Report Overview
The clot management devices market size was $2.13 billion in 2023. The market is expected to grow at a CAGR of more than 3% during 2023-2033. Clot management devices are used for the removal or dissolution of a clot from a blood vessel to restore proper blood circulation. Clot management devices are used as a routine procedure while performing percutaneous coronary intervention and to treat potentially life-threatening complications such as deep vein thrombosis (DVT) and pulmonary embolism (PE).
Clot Management Devices Market Outlook, 2023-2033 ($ Billion)
Buy the Full Report for More Insights into the Clot Management Devices Market Forecast
The Clot Management Devices market research report has been created to understand market behavior, which will help identify quantitative market trends in the cardiovascular devices therapeutic area. The model discusses in detail the impact of COVID-19 on the clot management devices market for the year 2020 and beyond. The report has extensively covered pipeline products and technologies, which will help in identifying companies with the most robust pipeline. This, in turn, will assist in predictive analysis for designing your in-licensing and out-licensing strategies.
Market Size (2023) | $2.13 billion |
CAGR (2023-2033) | >3% |
Forecast Period | 2023-2033 |
Historical Period | 2015-2022 |
Key Segments | · CDT Catheters
· Embolectomy Balloon Catheters · Thrombectomy Devices |
Key Regions | · North America
· Europe · Asia Pacific · South Central America · Middle East and Africa |
Leading Companies | · Inari Medical Inc
· Boston Scientific Corp · Penumbra Inc · Teleflex Inc · Edwards Lifesciences Corp |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Clot Management Devices Market Dynamics
Venous Thromboembolism is a common cause of mortality and affects a large portion of the global population. Anticoagulants are usually recommended for treating deep vein thrombosis, aiming mainly toward preventing pulmonary embolism and recurrent DVT. An increasing aging population, relatively quick procedure, improved revascularization rates, and a low risk of recurrence of deep vein thrombosis (DVT) or pulmonary embolism (PE) drive the clot management devices market.
Clot Management Devices Market Segments
The key segments in the clot management devices market are CDT catheters, embolectomy balloon catheters, and thrombectomy devices. Thrombectomy devices led the clot management devices market in 2023. Thrombectomy devices are used for the removal or dissolution of a clot from a blood vessel to restore proper blood circulation. This device is used as a routine procedure while performing percutaneous coronary intervention. Thrombectomy devices are also used to treat potentially life-threatening complications such as deep vein thrombosis (DVT) and pulmonary embolism (PE).
Clot Management Devices Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Segment Insights into the Clot Management Devices Market
Clot Management Devices Market Segmentation by Regions
The key regions in the clot management devices market are North America, Europe, Asia Pacific, South Central America, and the Middle East and Africa. In 2023, North America dominated the clot management devices market. The US has the largest contribution in both the regional and global markets. This trend is expected to continue throughout the forecast years. The increasing aging population and consequent increase in the incidence of venous thromboembolism are the main factors driving growth in the US, Canada, and Mexico clot management devices markets. Moreover, improvements in diagnostic techniques have also helped in early detection of thromboembolism resulting in a larger potential patient pool.
Clot Management Devices Market Analysis by Regions, 2023 (%)
Buy the Full Report for More Regional Insights into the Clot Management Devices Market
Clot Management Devices Market - Competitive Landscape
A few of the leading companies in the clot management devices market are:
- Inari Medical Inc
- Boston Scientific Corp
- Penumbra Inc
- Teleflex Inc
- Edwards Lifesciences Corp
Penumbra Inc. dominated the market in 2023.
Clot Management Devices Market Analysis by Companies, 2023 (%)
Buy the Full Report for More Company Insights into the Clot Management Devices Market
Segments Covered in the Report
Clot Management Devices Segments Outlook (Value, $ Billion, 2015-2033)
- CDT Catheters
- Standard CDT Catheters
- Ultrasound Assisted CDT Catheters
- Embolectomy Balloon Catheters
- Thrombectomy Devices
- Manual Aspiration Thrombectomy Devices
- Rotational Thrombectomy Devices
- Specialized Aspiration Thrombectomy Devices
- Thrombectomy Catheters
Clot Management Devices Regional Outlook (Value, $ Billion, 2015-2033)
- North America
- Europe
- Asia Pacific
- South Central America
- Middle East & Africa
Key Inclusions
Currently marketed Clot Management Devices and evolving competitive landscape:
- Insightful review of the key industry trends.
- Annualized total Clot Management Devices market revenue by segment and market outlooks from 2015-2033.
- Market-level data on units, average selling prices, and market values.
Global, Regional, and Country level market specific insights:
- Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Clot Management Devices market.
- Competitive dynamics insights and trends provided for the Clot Management Devices market.
Get an in-depth understanding of consumer behavior through the market access segment and the overview of the healthcare system. The report also offers information on reimbursement policies and the regulatory landscape.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, the report helps determine market trends through real-world data sources including government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Inari Medical Inc, Boston Scientific Corp, Penumbra Inc, Teleflex Inc, Edwards Lifesciences Corp, Medtronic Plc, Argon Medical Devices Inc, LeMaitre Vascular Inc, AngioDynamics Inc, Terumo Corp, Merit Medical Systems Inc, Cook Group Inc, Koninklijke Philips NV, Control Medical Technology LLC, and others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
Scope
This report provides:
- Insightful review of the key industry trends.
- Annualized total Clot Management Devices market revenue by segment and market outlooks.
- Market-level data on units, average selling prices, and market values.
- Global, regional, and country-level market-specific insights including qualitative market-specific information with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
- SWOT analysis for the Clot Management Devices market.
- Competitive dynamics insights and trends provided for the Clot Management Devices market.
- Country-specific overview of the healthcare system.
- Country-specific reimbursement policies.
- Country-specific medtech regulatory landscape.
Reasons to Buy
- Understand the impact of COVID-19 on the Clot Management Devices market.
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Clot Management Devices market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Clot Management Devices market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
- Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
- Track device sales in the global and country-specific Clot Management Devices market from 2015-2033.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Boston Scientific Corp
Penumbra Inc
Teleflex Inc
Edwards Lifesciences Corp
Medtronic Plc
Argon Medical Devices Inc
LeMaitre Vascular Inc
AngioDynamics Inc
Terumo Corp
Merit Medical Systems Inc
Cook Medical Inc
Koninklijke Philips NV
Control Medical Technology LLC
Others
Frequently asked questions
-
What was the clot management devices market size in 2023?
The clot management devices market size was $2.13 billion in 2023.
-
What will the clot management devices market growth rate be during the forecast period?
The clot management devices market is expected to grow at a CAGR of more than 3% during 2023-2033.
-
Which region dominated the clot management devices market in 2023?
North America dominated the overall clot management devices market in 2023.
-
Which segment led the clot management devices market in 2023?
Thrombectomy devices led the clot management devices market in 2023.
-
Which are the leading companies in the clot management devices market?
A few of the leading companies in the clot management devices market are Inari Medical Inc., Boston Scientific Corp, Penumbra Inc., Teleflex Inc., and Edwards Lifesciences Corp, among others.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.